How to Partner with a Telehealth Clinic: A Complete Guide

Why Telehealth Partnerships Are Expanding Rapidly

Telehealth use surged during the COVID-19 pandemic and has remained elevated. The Centers for Disease Control and Prevention reported that 37.0% of U.S. Adults used telemedicine in 2021, up from single-digit percentages in 2019 [1]. That sustained demand has created a large opportunity for businesses, health systems, employers, and individual clinicians to partner with established telehealth clinics rather than build their own infrastructure from scratch.

The Clinical Case for Telehealth

Remote care is not simply convenient. A 2023 JAMA Network Open analysis found that telehealth visits for chronic-disease management produced non-inferior glycemic outcomes compared with in-person visits for patients with type 2 diabetes, with HbA1c reductions of 0.8% in both cohorts over 12 months [2]. The American Diabetes Association's 2024 Standards of Care explicitly state, "telehealth technologies have significant potential to improve diabetes care and education" [3].

For hormone therapy specifically, the Endocrine Society's clinical practice guideline on testosterone therapy notes that follow-up monitoring can occur via telehealth when laboratory testing is coordinated locally [4]. These endorsements give partners confidence that telehealth-delivered clinical services meet guideline-level standards.

Market Drivers for Partnership Demand

Several forces push organizations toward partnership rather than independent clinic development. Building a de-novo telehealth clinic requires obtaining medical licenses in each target state (50 separate applications, fees ranging from $150 to $900 each), credentialing physicians, negotiating with pharmacy networks, and implementing a HIPAA-compliant electronic health record. A partnership with an existing clinic collapses that timeline from 18 to 36 months to roughly 60 to 120 days.

Employers are a major driver. The Kaiser Family Foundation 2023 Employer Health Benefits Survey found that 36% of large employers (200 or more workers) offered a telehealth benefit that included behavioral health, primary care, or chronic-disease management [5]. Businesses that want to offer these benefits without owning a clinic are natural partnership candidates.

Types of Telehealth Partnership Structures

Not all partnerships look the same. The structure you choose determines your liability exposure, revenue potential, and operational complexity.

Referral Partnerships

A referral partnership is the simplest entry point. Your organization refers patients or members to the telehealth clinic, and the clinic pays a referral fee per completed visit or per converted patient. The fee is typically $25, $150 per visit, depending on service type.

Referral fees in healthcare are tightly regulated. The federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b) prohibits paying or receiving remuneration to induce referrals of federal healthcare program patients [6]. Any referral fee arrangement must be structured under a recognized safe harbor, such as the personal services safe harbor, and should be reviewed by a healthcare attorney before execution.

White-Label Partnerships

In a white-label arrangement, the telehealth clinic provides clinical services under your brand. Patients see your logo, your app, and your intake forms, while the clinic's licensed providers handle diagnosis and prescribing. This is the preferred model for wellness brands, fitness companies, and employer benefit platforms that want a smooth patient experience without hiring clinicians.

White-label contracts are more complex. They require a detailed Brand License Agreement, a Business Associate Agreement under 45 CFR §164.502 [7], and clear indemnification language specifying which party bears liability for clinical decisions.

Technology and EHR Integration Partnerships

Software companies, wearable manufacturers, and laboratory networks often partner with telehealth clinics to feed data into the clinical workflow. A continuous glucose monitor company, for example, may integrate glucose data directly into the clinic's EHR so that a provider can review trends and adjust a GLP-1 dose without a separate patient-uploaded file. These partnerships are governed primarily by data-sharing agreements and must comply with the ONC's 21st Century Cures Act information-blocking rules [8].

Staffing and Locum Tenens Arrangements

Clinician staffing firms, nurse practitioner groups, and physician organizations may contract with a telehealth clinic to supply credentialed providers. The clinic owns the patient relationship and the platform; the staffing partner supplies the licensed workforce. Compensation is typically per-hour or per-visit, ranging from $85, $200/hour for nurse practitioners and $150, $350/hour for physicians, depending on specialty.

Legal and Regulatory Requirements You Must Verify

Compliance failures in telehealth carry civil and criminal penalties. Every potential partner should conduct formal due diligence before signing.

HIPAA and the Business Associate Agreement

Any entity that receives, transmits, or processes protected health information on behalf of a covered entity is a Business Associate under HIPAA [7]. The BAA must specify permissible uses of PHI, breach notification timelines (60 days maximum under 45 CFR §164.412), and data return or destruction procedures at contract end. The HHS Office for Civil Rights settled 22 HIPAA enforcement actions in fiscal year 2023, with penalties ranging from $30,000 to $4.75 million [9].

DEA Registration and the Ryan Haight Act

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 prohibits prescribing Schedule II, V controlled substances via telemedicine without a prior in-person evaluation, with limited exceptions [10]. The DEA's 2023 proposed rule on telemedicine prescribing would have created a special telemedicine registry; that rule was withdrawn and replaced by a temporary extension of COVID-era flexibilities through December 31, 2025 [11].

For GLP-1 agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), no controlled-substance issue applies because these are non-scheduled drugs. For testosterone cypionate (Schedule III) or buprenorphine, the Ryan Haight rules apply in full and must be addressed in the partnership agreement.

State Medical Practice Acts and Licensure

A telehealth clinic may prescribe to a patient only in the state where the patient is located at the time of the visit, per the majority interpretation of state medical practice acts [12]. Verify that the clinic holds active licenses in every state where your patients or members reside. The Interstate Medical Licensure Compact currently facilitates expedited licensure in 40 participating states [13], but compact membership does not eliminate the licensure requirement.

FTC and Advertising Compliance

Partners that market the clinic's services must comply with FTC endorsement guidelines (16 CFR Part 255), which require disclosure of material connections [14]. A wellness brand that refers customers to a white-label telehealth service and earns a per-conversion fee must disclose that relationship in all marketing materials.

GLP-1 and Hormone Therapy Partnerships: Specific Considerations

Many telehealth partnership inquiries center on high-demand services: GLP-1 weight-loss programs, testosterone replacement therapy (TRT), and hormone replacement therapy (HRT) for menopause. Each area carries specific clinical and regulatory considerations.

GLP-1 Prescribing Partnerships

Semaglutide 2.4 mg (Wegovy) produced 14.9% mean body-weight loss at 68 weeks versus 2.4% with placebo in STEP-1 (N=1,961, P<0.001) [15]. Tirzepatide 15 mg produced 20.9% mean weight loss at 72 weeks in SURMOUNT-1 (N=2,539, P<0.001) [16]. Demand for these agents is high and supply has been intermittently constrained.

The FDA's 503A and 503B compounding regulations permit compounding pharmacies to compound semaglutide only when the FDA-approved product is on the drug shortage list [17]. As of early 2025, the FDA removed semaglutide from its shortage list, which restricts 503A compounding significantly. Partners must verify that their clinic's GLP-1 formulary uses FDA-approved branded products (Wegovy, Ozempic, Zepbound, Mounjaro) or compounded products only under circumstances that comply with current FDA guidance [17].

The HealthRX clinical team uses a four-step GLP-1 partnership qualification framework: (1) confirm the clinic uses FDA-approved agents or shortage-compliant compounded agents; (2) verify the prescribing provider is licensed in the patient's state; (3) confirm baseline labs (HbA1c, lipid panel, CMP) are ordered at intake; and (4) ensure a medically supervised titration protocol matches the manufacturer's approved schedule (semaglutide: 0.25 mg/week for 4 weeks, escalating to 2.4 mg/week over 16 to 20 weeks).

TRT Partnership Considerations

Testosterone cypionate is a Schedule III controlled substance under the Controlled Substances Act [10]. Any telehealth clinic prescribing TRT must hold DEA registration, and prescribing providers must be individually DEA-registered. The Endocrine Society guideline on male hypogonadism recommends confirming low serum testosterone (below 300 ng/dL on two morning measurements) before initiating therapy [4]. A partner clinic that does not require pre-treatment labs is a compliance and liability risk.

The American Urological Association's 2024 guideline on testosterone deficiency states, "clinicians should measure total testosterone using an accurate and reliable assay" and specifies that liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the preferred method [18]. Verify that your prospective clinic partner uses LC-MS/MS or an equivalent validated assay, not immunoassay alone.

HRT and Menopause Care

The Menopause Society (formerly NAMS) 2023 position statement confirms that hormone therapy is the most effective treatment for vasomotor symptoms and that benefit-risk ratio is favorable for most women under age 60 or within 10 years of menopause onset [19]. Telehealth delivery of HRT is guideline-supported when the prescribing provider reviews a complete medical and family history and orders baseline labs.

Partners pairing HRT services with a telehealth clinic should confirm the clinic's intake process includes assessment of contraindications: personal or family history of breast cancer, VTE history, unexplained vaginal bleeding, and active liver disease [19].

Structuring the Partnership Agreement

A telehealth partnership agreement needs more than a rate card and a handshake. The following sections must appear in any compliant contract.

Revenue and Fee Structures

Common models include: a flat referral fee per completed visit, a percentage of monthly subscription revenue (typically 10 to 25%), a per-member-per-month fee for employer benefit arrangements, or an equity stake in exchange for significant patient volume or technology contribution. All fee arrangements involving federal healthcare program patients must pass Anti-Kickback Statute scrutiny [6].

Service Level Agreements

Specify minimum clinician response times (48 hours for new patient intake is a standard benchmark), after-hours coverage protocols, and escalation pathways for clinical emergencies. The National Committee for Quality Assurance (NCQA) telehealth standards recommend documented workflows for care transitions and emergency referrals [20].

Exclusivity and Non-Compete Clauses

Some clinic partners will request geographic or category exclusivity. Evaluate these carefully. An exclusive arrangement that prevents you from working with other clinics for 24 to 36 months in your core market is a significant business risk if the clinic underperforms. Limit exclusivity to 12 months with renewal options tied to volume milestones.

Liability and Indemnification

Clinical malpractice liability stays with the licensed provider and the clinic, not the referring partner, provided the partner does not direct clinical decision-making. Confirm this allocation explicitly in the indemnification clause. The clinic should carry a minimum of $1 million per occurrence / $3 million aggregate in professional liability coverage, verified by a current certificate of insurance.

Termination and Data Return

The contract must specify that upon termination, all patient data returns to the originating party or is destroyed per HIPAA standards within 30 days, and that the clinic cannot continue marketing to referred patients under your brand after termination.

Due Diligence Checklist Before Signing

Conducting due diligence on a potential telehealth clinic partner protects your organization from regulatory, financial, and reputational risk.

Licensure Verification

Request a complete list of active state medical licenses for all prescribing providers and confirm each license is in good standing via the relevant state medical board's public lookup tool. For clinics using nurse practitioners as primary prescribers, confirm each NP's scope of practice in each state covers the intended services, since 27 states still require physician supervision for NP prescribing [12].

Formulary and Pharmacy Relationships

Ask for the clinic's current formulary and the names of all pharmacy partners. A telehealth clinic that routes prescriptions exclusively through one compounding pharmacy with no PCAB accreditation or 503B designation warrants deeper scrutiny. PCAB accreditation is granted by the Pharmacy Compounding Accreditation Board and signals adherence to USP Chapter 795 and 797 standards [21].

Clinical Protocol Review

Request copies of the clinic's clinical protocols for each service you plan to offer under the partnership. A GLP-1 protocol should include patient selection criteria (BMI 30 or above, or BMI 27 or above with a weight-related comorbidity, per FDA labeling [22]), contraindication screening (personal or family history of medullary thyroid carcinoma or MEN2), baseline labs, and a titration schedule. A TRT protocol should include pre-treatment testosterone levels, hematocrit monitoring every 3 to 6 months, and PSA screening per Endocrine Society guidance [4].

Complaint and Adverse Event Records

Ask whether the clinic has received any state medical board complaints, DEA actions, or FDA warning letters in the past 3 years. This information may be partially public through state board websites and the FDA's Warning Letters database [23]. A single substantiated complaint is not necessarily disqualifying, but a pattern of regulatory action is.

Operational Integration: Getting to Go-Live

Once the contract is signed, integration requires coordinating across technology, clinical operations, and marketing.

Technology Onboarding

Most telehealth clinics operate on one of four EHR platforms: Osmind, Canvas Medical, Athenahealth, or a proprietary system. API-based integration for referral tracking, patient status updates, and lab results is preferable to manual CSV exports. Confirm data transfer encryption meets AES-256 standards and that the integration is tested in a staging environment before patient data flows live.

Staff Training

Your patient-facing team needs to understand what the clinic can and cannot prescribe, what the intake process looks like, and how to handle patient questions about wait times, refills, and side effects. A structured 90-minute training session with the clinic's clinical operations team, delivered before go-live, reduces patient-facing errors significantly.

Marketing and Consent Materials

All marketing materials referencing the clinic's services must be reviewed by your legal team and the clinic's compliance officer before publication. Patient consent forms must clearly identify the prescribing entity (the clinic, not your brand) and disclose the telehealth nature of the encounter, as required by state informed-consent laws in at least 18 states [12].

Monitoring Partnership Performance

A telehealth partnership should be evaluated on clinical and operational metrics at 30, 60, and 90 days post-launch, then quarterly.

Key Performance Indicators

Track: intake-to-first-prescription time (target <5 business days), patient satisfaction scores (target NPS 50 or above), 90-day patient retention rate (target 70% or above for chronic-disease programs), adverse event rate, and refill fulfillment time. The Agency for Healthcare Research and Quality recommends that telehealth programs track patient-reported outcome measures at regular intervals to demonstrate clinical value [24].

Clinical Outcome Tracking

For GLP-1 partnerships, track mean weight loss at 12 weeks, 24 weeks, and 52 weeks against published benchmarks (STEP-1: 14.9% at 68 weeks [15]). For TRT, track mean total testosterone at 3 months against the clinic's target range (typically 400 to 700 ng/dL). Outcome data strengthens your negotiating position at contract renewal and supports marketing claims.

Renegotiation Triggers

Build explicit renegotiation triggers into the contract: if the intake-to-prescription time exceeds 7 business days for two consecutive months, if patient NPS falls below 40, or if the clinic fails to maintain licensure in any state covering more than 5% of your patient population. Triggers with defined remediation periods (30 days to cure) protect your patients and your business.